Longuet C - Search Results

1

Clinical, virological, and biological parameters associated with outcomes of Ebola virus infection in Macenta, Guinea.

Vernet MA, Reynard S, Fizet A, Schaeffer J, Pannetier D, Guedj J, Rives M, Georges N, Garcia-Bonnet N, Sylla AI, Grovogui P, Kerherve JY, Savio C, Savio-Coste S, de Séverac ML, Zloczewski P, Linares S, Harouna S, Abdoul BM, Petitjean F, Samake N, Shepherd S, Kinda M, Koundouno FR, Joxe L, Mateo M, Lecine P, Page A, Tchamdja TM, Schoenhals M, Barbe S, Simon B, Tran-Minh T, Longuet C, L'Hériteau F, Baize S. Vernet MA, et al. Among authors: longuet c. JCI Insight. 2017 Mar 23;2(6):e88864. doi: 10.1172/jci.insight.88864. JCI Insight. 2017. PMID: 28352651 Free PMC article.

2

Clinical evaluation of the BioFire FilmArray^® BioThreat-E test for the diagnosis of Ebola Virus Disease in Guinea.

Gay-Andrieu F, Magassouba N, Picot V, Phillips CL, Peyrefitte CN, Dacosta B, Doré A, Kourouma F, Ligeon-Ligeonnet V, Gauby C, Longuet C, Scullion M, Faye O, Machuron JL, Miller M. Gay-Andrieu F, et al. Among authors: longuet c. J Clin Virol. 2017 Jul;92:20-24. doi: 10.1016/j.jcv.2017.04.015. Epub 2017 May 1. J Clin Virol. 2017. PMID: 28505570

3

Experimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical Trial.

Dunning J, Sahr F, Rojek A, Gannon F, Carson G, Idriss B, Massaquoi T, Gandi R, Joseph S, Osman HK, Brooks TJ, Simpson AJ, Goodfellow I, Thorne L, Arias A, Merson L, Castle L, Howell-Jones R, Pardinaz-Solis R, Hope-Gill B, Ferri M, Grove J, Kowalski M, Stepniewska K, Lang T, Whitehead J, Olliaro P, Samai M, Horby PW; RAPIDE-TKM trial team. Dunning J, et al. PLoS Med. 2016 Apr 19;13(4):e1001997. doi: 10.1371/journal.pmed.1001997. eCollection 2016 Apr. PLoS Med. 2016. PMID: 27093560 Free PMC article. Clinical Trial.

4

Association between discordant immunological response to highly active anti-retroviral therapy, regulatory T cell percentage, immune cell activation and very low-level viraemia in HIV-infected patients.

Saison J, Ferry T, Demaret J, Maucort Boulch D, Venet F, Perpoint T, Ader F, Icard V, Chidiac C, Monneret G; Lyon HIV Cohort Study. Saison J, et al. Clin Exp Immunol. 2014 Jun;176(3):401-9. doi: 10.1111/cei.12278. Clin Exp Immunol. 2014. PMID: 24460818 Free PMC article.

5

Report of the 2014 Cent Gardes HIV Vaccine Conference - Part 1: Neutralizing Antibodies; Fondation Mérieux Conference Center, Veyrier du Lac, France, 5-7 October 2014.

Girard MP, Picot V, Longuet C, Nabel GJ. Girard MP, et al. Among authors: longuet c. Vaccine. 2015 Jul 17;33(31):3605-8. doi: 10.1016/j.vaccine.2015.03.004. Epub 2015 Mar 11. Vaccine. 2015. PMID: 25769208

6

Report of the 2014 Cent Gardes HIV Vaccine Conference-Part 2: Cell-mediated immunity, mucosal protection, and clinical trials: Fondation Mérieux Conference Center, Veyrier du Lac, France, 5-7 October, 2014.

Girard MP, Picot V, Longuet C, Nabel GJ. Girard MP, et al. Among authors: longuet c. Vaccine. 2015 Aug 7;33(33):4051-5. doi: 10.1016/j.vaccine.2015.06.074. Epub 2015 Jul 2. Vaccine. 2015. PMID: 26143614

7

Report of the Cent Gardes HIV Vaccines Conference, Part 2: The cellular immune response. Fondation Mérieux Conference Center, Veyrier-du-Lac, France, 25-27 October 2015.

Girard MP, Le-Grand R, Picot V, Longuet C, Nabel GJ. Girard MP, et al. Among authors: longuet c. Vaccine. 2016 Nov 4;34(46):5470-5473. doi: 10.1016/j.vaccine.2016.09.034. Epub 2016 Sep 28. Vaccine. 2016. PMID: 27692524 No abstract available.

8

Report of the Cent Gardes HIV Vaccines Conference. Part 1: The antibody response; Fondation Mérieux Conference Center, Veyrier-du-Lac, France, 25-27 October 2015.

Girard MP, Le-Grand R, Picot V, Longuet C, Nabel GJ. Girard MP, et al. Among authors: longuet c. Vaccine. 2016 Jun 30;34(31):3557-61. doi: 10.1016/j.vaccine.2016.05.024. Epub 2016 May 20. Vaccine. 2016. PMID: 27216761

9

Report of the Cent Gardes HIV Vaccine Conference: The B-cell Response to HIV. Part 1: Broadly Neutralizing Antibodies Fondation Mérieux Conference Center, Veyrier du Lac, France, 5-7 November 2012.

Girard MP, Picot V, Longuet C, Nabel GJ. Girard MP, et al. Among authors: longuet c. Vaccine. 2013 Jun 24;31(29):2979-83. doi: 10.1016/j.vaccine.2013.02.068. Epub 2013 Mar 13. Vaccine. 2013. PMID: 23499518

10

Report of the Cent Gardes HIV Vaccine Conference: The B-cell response to HIV. Part 2: Non-neutralizing antibodies: Fondation Mérieux Conference Center, Veyrier du Lac, France 5-7 November 2012.

Girard MP, Picot V, Longuet C, Nabel GJ. Girard MP, et al. Among authors: longuet c. Vaccine. 2013 Jun 24;31(29):2984-7. doi: 10.1016/j.vaccine.2013.02.067. Epub 2013 Apr 18. Vaccine. 2013. PMID: 23602538

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Search Page

Filters